{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:54:10Z","timestamp":1781610850927,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Open fractures, particularly Gustilo-Anderson grade III injuries, carry high risks of infection. This cohort study compared the effectiveness of three prophylactic antibiotic regimens in reducing a range of infection-related outcomes, including infection markers (ESR, CRP), wound colonization, clinical infections, fever, cellulitis, and abscess formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective cohort study, 600 patients aged 18\u201385 years with open fractures were enrolled at Shahid Bahonar Hospital, Iran (2020\u20132022). Participants were grouped by clinician-selected regimens: Group A (Cefazolin 1\u00a0g every 6\u00a0h\u2009+\u2009amikacin), Group B (Cefazolin 2\u00a0g every 8\u00a0h\u2009+\u2009amikacin), and Group C (Vancomycin 2\u00a0g every 12\u00a0h\u2009+\u2009amikacin). Multivariable logistic regression adjusted for confounders (age, fracture severity). Missing data (&lt;\u20095%) were imputed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 978 patients screened, 600 completed follow-ups. Baseline demographics (mean age: 31.2 years; 82% male) were balanced. Group C had lower rates of elevated ESR (4.8% vs. 8.0% in Group A; adjusted RR\u2009=\u20090.61, 95% CI: 0.40\u20130.92), clinical infection (4.7% vs. 8.0%; RR\u2009=\u20090.58, CI: 0.38\u20130.89), and deep infection (2.7% vs. 5.3%; RR\u2009=\u20090.51, CI: 0.29\u20130.90). Minor adverse events (rash\/nausea) were balanced across all groups (5.5% overall), with no significant differences in incidence or type between regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vancomycin-amikacin was associated with reduced infection markers and complications compared to cefazolin regimens in this observational cohort, supporting its consideration in high-risk settings. Causality requires confirmation through randomized trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-025-09063-3","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T06:38:51Z","timestamp":1755758331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of prophylactic antibiotic regimens in preventing infection in open fractures: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohammad","family":"Sheibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Sadeghifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriyar","family":"Shafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Azarsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sajjad","family":"Mirhoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mohammaditabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham al-Sadat Seyyed","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"9063_CR1","doi-asserted-by":"publisher","unstructured":"Court-Brown CM, Rimmer S, Prakash U, McQueen MM. The epidemiology of open long bone fractures. Injury. 1998;297:529\u2009\u2013\u200934. https:\/\/doi.org\/10.1016\/s0020-1383(98)00125-9.\u00a0","DOI":"10.1016\/s0020-1383(98)00125-9"},{"issue":"4","key":"9063_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2106\/00004623-197658040-00004","volume":"58","author":"RB Gustilo","year":"1976","unstructured":"Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58(4):453\u20138.","journal-title":"J Bone Joint Surg Am"},{"key":"9063_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00003086-198906000-00006","volume":"243","author":"MJ Patzakis","year":"1989","unstructured":"Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989;243:36\u201340.","journal-title":"Clin Orthop Relat Res"},{"key":"9063_CR4","doi-asserted-by":"publisher","DOI":"10.2106\/jbjs.Rvw.17.00197","volume":"7","author":"Y Chang","year":"2019","unstructured":"Chang Y, Bhandari M, Zhu KL, Mirza RD, Ren M, Kennedy SA, et al. Antibiotic prophylaxis in the management of open fractures: a systematic survey of current practice and recommendations. JBJS Rev. 2019;7: 2e1. https:\/\/doi.org\/10.2106\/jbjs.Rvw.17.00197.","journal-title":"JBJS Rev"},{"issue":"Suppl 4","key":"9063_CR5","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/s0020-1383(15)30027-9","volume":"46","author":"R Otchwemah","year":"2015","unstructured":"Otchwemah R, Grams V, Tjardes T, Shafizadeh S, B\u00e4this H, Maegele M, et al. Bacterial contamination of open fractures - pathogens, antibiotic resistances and therapeutic regimes in four hospitals of the trauma network cologne, Germany. Injury. 2015;46(Suppl 4):S104\u20138. https:\/\/doi.org\/10.1016\/s0020-1383(15)30027-9.","journal-title":"Injury"},{"key":"9063_CR6","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berr\u00edos-Torres","year":"2017","unstructured":"Berr\u00edos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:8784\u201391. https:\/\/doi.org\/10.1001\/jamasurg.2017.0904.","journal-title":"JAMA Surg"},{"key":"9063_CR7","doi-asserted-by":"crossref","unstructured":"Patzakis MJ, Wilkins J, Moore TM. Use of antibiotics in open tibial fractures. Clin Orthop Relat Res 1983;178:31\u20135.","DOI":"10.1097\/00003086-198309000-00005"},{"key":"9063_CR8","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1302\/2046-3758.77.Bjr-2018-0043.R1","volume":"7","author":"M Morgenstern","year":"2018","unstructured":"Morgenstern M, Vallejo A, McNally MA, Moriarty TF, Ferguson JY, Nijs S, et al. The effect of local antibiotic prophylaxis when treating open limb fractures: A systematic review and meta-analysis. Bone Joint Res. 2018;7:7447\u201356. https:\/\/doi.org\/10.1302\/2046-3758.77.Bjr-2018-0043.R1.","journal-title":"Bone Joint Res"},{"key":"9063_CR9","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.5435\/jaaos-d-18-00193","volume":"28","author":"MR Garner","year":"2020","unstructured":"Garner MR, Sethuraman SA, Schade MA, Boateng H. Antibiotic prophylaxis in open fractures: evidence, evolving issues, and recommendations. JAAOS - J Am Acad Orthop Surg. 2020;28:8309\u201315. https:\/\/doi.org\/10.5435\/jaaos-d-18-00193.","journal-title":"JAAOS - J Am Acad Orthop Surg"},{"issue":"11","key":"9063_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/bot.0000000000000090","volume":"28","author":"CA Collinge","year":"2014","unstructured":"Collinge CA, McWilliam-Ross K, Kelly KC, Dombroski D. Substantial improvement in prophylactic antibiotic administration for open fracture patients: results of a performance improvement program. J Orthop Trauma. 2014;28(11):620\u20135. https:\/\/doi.org\/10.1097\/bot.0000000000000090.","journal-title":"J Orthop Trauma"},{"issue":"22","key":"9063_CR11","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2106\/jbjs.O.00072","volume":"97","author":"CR Lawing","year":"2015","unstructured":"Lawing CR, Lin FC, Dahners LE. Local injection of aminoglycosides for prophylaxis against infection in open fractures. J Bone Joint Surg Am. 2015;97(22):1844\u201351. https:\/\/doi.org\/10.2106\/jbjs.O.00072.","journal-title":"J Bone Joint Surg Am"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-09063-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:19:57Z","timestamp":1781608797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-025-09063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9063"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-09063-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were carried out in accordance with the ethical guidelines outlined in the Declaration of Helsinki.The ethics committee of Kerman University of Medical Sciences approved the study protocol (IR.kmu.REC.1394.528) and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Prospective design, exposure classification, confounder adjustment, outcome blinding, and attrition reporting.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"STROBE compliance"}}],"article-number":"809"}}